Jasper Therapeutics Inc

JSPRNASDAQ · USD
0.63USD0.00 (+9.16%)
112

Jasper Therapeutics Inc (JSPR) Implied Volatility Current

JSPR implied volatility is 708%. IV Rank is 90%, placing current premiums in the top of their 52-week range.

Read more

Tracking JSPR implied volatility helps you identify when options premiums on Jasper Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Jasper Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when JSPR IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Jasper Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For JSPR, tracking metrics like JSPR IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on JSPR signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy.

It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where JSPR implied volatility sits today versus where it has been. Our scanner ranks Jasper Therapeutics Inc implied volatility against its historical range, surfaces extremes in JSPR IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Jasper Therapeutics Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
90.48%IV Rank
High

IV is near its yearly peak - premiums are expensive, favoring sellers.

Implied Volatility (30d)708.06%

IV Rank90.48%

Historical Volatility (30d)93.37%

IV - HV+614.69%

As of September 17, 2026

Trade options with IV on your side

Track JSPR IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial